InvestorsHub Logo
Followers 0
Posts 5
Boards Moderated 0
Alias Born 08/26/2008

Re: None

Friday, 07/17/2015 9:58:02 AM

Friday, July 17, 2015 9:58:02 AM

Post# of 243
posted on the old LVNVF yahoo mb but here is my thoughts on SCIVAC:

SCIVAC connections: CLS therapeutics and Xenetic Biosciences
CLS therapeutics recently acquired a large number of shares of scivac. The agreement allows scivac to develop and commercialize a bunch of their patents and pre-clinical research. They have a great IP portfolio and looks promising. In addition, Russian OJSC Pharmsynthez and their management (including Dmitry Genkin- who also was involved with FDS pharma) owns a large part of CLS therapeutics as well as Xenetic Biosciences (XBIO). XBIO recently came out with positive data on their long acting EPO drug for CKD and other diseases. They also have a long acting oxyntomodulin (for diabetes).... Sound familiar? Thats because OPKO is working on drugs for long acting oxyntomodulin (acquired by OPKO during Prolor deal). Also OPKO is working on CKD drugs

OH THE CIRCLE OF CONNECTIONS.... check out these companies... they will all end up being acquired by OPKO within time... FROST is building an empire, glad i can be a part of it.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VBIV News